Enyedy punts | IMGN Message Board Posts

ImmunoGen, Inc.

  IMGN website

IMGN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  50282 of 50372  at  1/17/2020 9:32:30 AM  by

Biotechbeagle


 In response to msg 50279 by  Biotechbeagle
view thread

Re: Enyedy punts

Thanks for the update and perspective! What we learned from Sorvaya is when things are quiet or they are missing a timeline they can be discussing a different path with the FDA and possibly monetizing and asset or working a new partnership if delaying financial guidance. I also wouldn’t be surprised if an outright acquisition is also on the table given the assets, how lean they are and need for cash. And of course the hunger of big pharma or biotech to bolster their pipelines with late stage assets.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 323
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
50283 Re: Enyedy punts GaryM 0 1/17/2020 4:22:41 PM






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...